
The neuroprotective effect of lovastatin on MPP+-induced neurotoxicity is not mediated by PON2
Keywords: MPP+, 1-methyl-4-phenylpyridinium; PD, Parkinson's disease; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydrophenylpyridine; MAO-B, monoamine oxidase B; DA, dopamine; ROS, reactive oxidant species; PON2, paraoxonase-2; HVA, homovanillic acid; DOPAC, 3,4-dihydrox